Homeβ€ΊSearchβ€ΊCancer Biology and Therapy

Cancer Biology and Therapy

Taylor and Francis Ltd. Β· United States Β· Est. 1898

ISSN1538-4047eISSN1555-8576
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
154
days submission β†’ published
measured Β· last 19 articles Β· accept 144d
11
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
1.407
H-Indexi
152
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.723
Total Worksi
5,210
Total Citationsi
167,022
2yr Mean Citednessi
5.96
Open Impact Factor alternative

Aims & Scope

Subject areas: Oncology; Molecular Medicine; Pharmacology; Cancer Research.

General Information

Country / RegionUnited States
Primary LanguageEnglish
1st Year Published1898
FrequencySemimonthly, 2009-
StatusActive (last: 2026)
Total Publications5,210
Publisher OrgTaylor & Francis
OA Since2021
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~11 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
Scholars PortalCLOCKSSNational Digital Preservation Program, China; Library of CongressLOCKSSPorticoPMC

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
Taylor and Francis Ltd.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1538-4047 / 1555-8576
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
Scholars Portal, CLOCKSS, National Digital Preservation Program, China; Library of Congress, LOCKSS, Portico, PMC
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
119
5.5k
2019
117
2.1k
2020
57
995
2021
65
1.4k
2022
88
1.2k
2023
115
1.3k
2024
88
293
2025
43
1
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Molecular MedicineQ1
OncologyQ1
PharmacologyQ1
Cancer ResearchQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Molecular MedicinePharmacologyCancer ResearchOncology

Research Topics (OpenAlex)

Cancer-related Molecular PathwaysCancer, Hypoxia, and MetabolismRNA modifications and cancerCell death mechanisms and regulationCancer Cells and MetastasisEpigenetics and DNA MethylationCancer Research and TreatmentsMicroRNA in disease regulationCancer Genomics and DiagnosticsCancer-related molecular mechanisms research

Frequently asked questions about Cancer Biology and Therapy

Is Cancer Biology and Therapy a predatory journal?

PubScope has no integrity flags on record for Cancer Biology and Therapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Cancer Biology and Therapy?

Cancer Biology and Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 5.96.

Is Cancer Biology and Therapy indexed in Scopus and Web of Science?

Cancer Biology and Therapy is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Cancer Biology and Therapy?

Subject areas: Oncology; Molecular Medicine; Pharmacology; Cancer Research.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref